I-Vayarin "yokutya kwezokwelapha" ezingasetyenziswa "kwi-kliniki yokutya ukutya" kwabantwana abane-ADHD.
Vayarin kwi-ADHD
I-Vayarin ingasetyenziselwa ukuphatha "ukungalingani kwamanye amapilisi anxulumene ne-ADHD kubantwana ."
Olunye uphando lubonisa ukuba i-Vayarin iyanciphisa iimpawu ze-ADHD zakudala xa kuthelekiswa ne-placebo, kubandakanywa ukungalindelekanga , ukunyanzeliswa, nokungazinzi kunye nokungafuneki.
I-Vayarin yindlela yamachiza, ifom ye-omega-3 fatty acids. Ezinye iibakala ziquka ukuba:
- I-Vayarin iqukethe i-phosphatidylserine (PS), i-EPA, kunye ne-DHA
- I-Vayarin yonyango olungenakuvuselela i-ADHD
- Umlinganiselo oqhelekileyo weVayarin "ii-capsules 2 ngosuku okanye njengoko zikhokelwa ngugqirha."
- Nangona kungekho sikhokelo seminyaka esemthethweni seVayarin, safundiswa kubantwana phakathi kweminyaka eyi-6 no-13.
- I-Vayarin ifunyenwe ukuba ibekezeleleke ngaphandle "kweziganeko ezimbi."
Intengiso ephakanyisiweyo yokuthengisa impahla yeVayarin i malunga ne-$ 60 kwaye ingaqhelekanga i-inshurensi.
I-Omega-3 kunye ne-ADHD
Ukuba i-ADHD ingaphathwa nge-omega-3 fatty acids ayikho into entsha.
UDkt. AJ Richardson ushicilele iphepha, "i-Acatty Acids kwiDyslexia, i-Dyspraxia, ADHD kunye ne-Autistic Spectrum," ngo-2001 ephakamisa ukuba "ukungaphumeleli okanye ukungalingani kwamanye amaninzi angama-fatty acids (HUFA) ye-omega-3 kunye ne-omega-6 series inokufaka isandla kwizinto ezibini kunye nokubonakaliswa kwe-dyslexia, i-dyspraxia, i-ADHD kunye ne-autism. "
Kwaye u-meta-analysis of 2011 kwiimvavanyo ezili-10 kwi-Journal of the American Academy of Child & Adolescent Psychiatry ye-Omega-3 fatty acid supplementation yabonisa umphumo omncinci kodwa obalulekileyo ekuphuculeni iimpawu ze- ADHD . " Kwakhona kucatshangelwa ukuba i-omega-3 fatty acids inokukunceda ukuphatha abantu abanexinzelelo, ukuphazamiseka kwengqondo kunye nezinye izifo zengqondo .
Olunye uhlalutyo lwe-meta ngo-2014 olupapashwe kwiphepha le-PLEFA lifumene ukuba i-polyunsaturated fatty acids supplementation (PUFA) ye-ADHD yahlanganiswa ne:
- ukwehla okuncinci kwiimpawu ze-ADHD ezidibeneyo
- iphumelele ngakumbi kwii-PUFA ezithile zeempawu ezingalindelekanga
Kodwa nakweli sifundo, iziphumo zafunyanwa kuphela kwizibalo zabazali, kwaye kungekhona kootitshala okanye izilinganiso zonyango.
Yintoni Oyaziyo NgaVayarin kwi-ADHD
Ukongezelela kwezi ngcebiso, ezinye izinto ezaziyo malunga neVayarin ziquka ukuba:
- I-FDA ithi ukutya kwezokwelapha "kukutya okuqulunqwe ukuba kusetshenziswe okanye kulawulwa ngokungenisiweyo phantsi kolawulo lugqirha, kwaye lujoliswe ekuphathweni okuthe ngqo kwesifo okanye imeko apho iimfuno zesondlo ezihlukeneyo, ezisekelwe kwiingqinisiso imigaqo yenzululwazi, isungulwa ngolu vavanyo lwezokwelapha. "
- Gcina ukhumbule ukuba uhlalutyo lwe-omega-3 olukhankanywe ngentla lucetyiswa ukuba "unike ubungqina bokusebenza okuthobekileyo kwe-omega-3 fatty acid supplementation kunye neprofayili ye-omega-3 fatty supplementation, ngokukodwa ngamanani aphezulu I-EPA, isicwangciso esilungileyo sokwenza unyango njengokongeza kwi-pharmacotherapy yendalo okanye ezo ntsapho ezingenakusebenzisa i-psychopharmacologic agents. " Ngoko ukufundiswa akuzange kucebise ukusebenzisa i-omega-3 unyango ngokwabo kubantwana abaneempawu ze-ADHD ezibalulekileyo kodwa kunoko bacebisa ukuba banezezinye izidakamizwa ze-ADHD.
Nangona i-Vayarin inezo zonke iindleko ze-ADA ezigunyazisiweyo zezidakamizwa ezigqityiweyo, zizalisekile ngeSaziso soLwazi lokuBhala, kubalulekile ukukhumbula engokutya kokonyango okungafuneki ukuhlaziywa kwangaphambili kwemarike okanye ukuvunyelwa ngu-FDA, kwaye akudingeki ukuba ibhaliswe kunye ne-FDA.
Imithombo:
> I-Bloch MH, i-Qawasmi A. Omega-3 ye-fatty supplementation ekwenzeni unyango lwabantwana abanengxaki yokunqongophala / ukuphazamiseka kwesifo se-disorder symptomatology: ukuphononongwa ngokuchanekileyo kunye nokuhlaziywa kwemeta. J Am Academy Adolesc Psychiatry 2011; 50 (10): 991-1000.
FDA. Isikhokelo Soshishino: Imibuzo Ebuzwa Ngokuphindaphindiweyo Ngokutya Kwezonyango. Meyi 1997; Meyi 2007.
Manor I., Impembelelo ye-phosphatidylserine equkethe i-Omega3 e-fatty-acids kwi-attention-loss defence ye-disorder symptoms kubantwana: Iilingo ezilawulwa yi-placebo ezilawulwa kabini, zilandelwe yandisa i-label. Eur Psychiatry. 2011 Julayi 30.
Mischoulon, David. I-Omega-3 Acatty Acids kwi-Psychiatry. Iiklinikhi zeeNgqondo zaseNyakatho Melika, uMqulu 36, Ingxelo 1, Matshi 2013, iphepha 15-23.
I-Puri, i-Basant K. Yiyiphi i-polyunsaturated fatty acids esebenzayo kubantwana abanomdla-ukungaphumeleli kwimeko yokufumana ingxaki yokufumana i-PUFA yokuxhaswa? I-acidi e-fatty iqinisekisile ukuhlaziywa kwe-meta-regression yezilingo ezilawulwa ngokungahleliwe. I-Prostaglandins, iLeukotrienes kunye ne-Essential Fatty Acids (PLEFA). Umqulu 90, Issue 5, Meyi 2014, iphepha 179-189
Vayarin Ukunyathelisa i-Information Sheet. ISityhilelo 7/12.